Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1961 1
1963 1
1974 2
1975 4
1976 7
1977 14
1978 16
1979 25
1980 47
1981 58
1982 65
1983 54
1984 71
1985 60
1986 55
1987 58
1988 82
1989 107
1990 131
1991 130
1992 150
1993 144
1994 149
1995 154
1996 153
1997 147
1998 132
1999 150
2000 147
2001 141
2002 180
2003 186
2004 135
2005 160
2006 161
2007 174
2008 169
2009 165
2010 193
2011 215
2012 235
2013 224
2014 231
2015 243
2016 255
2017 238
2018 257
2019 289
2020 317
2021 374
2022 345
2023 336
2024 342
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,305 results

Results by year

Filters applied: . Clear all
Page 1
Ursodiol for all?
Lee SD, Surawicz CM. Lee SD, et al. Am J Gastroenterol. 2001 Dec;96(12):3437-8. doi: 10.1111/j.1572-0241.2001.05373.x. Am J Gastroenterol. 2001. PMID: 11774966 No abstract available.
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-beta degradation.
Shen Y, Lu C, Song Z, Qiao C, Wang J, Chen J, Zhang C, Zeng X, Ma Z, Chen T, Li X, Lin A, Guo J, Wang J, Cai Z. Shen Y, et al. Nat Commun. 2022 Jun 14;13(1):3419. doi: 10.1038/s41467-022-31141-6. Nat Commun. 2022. PMID: 35701426 Free PMC article.
Here, we show that the clinically approved compound ursodeoxycholic acid (UDCA), by degrading TGF-beta, enhances antitumor immunity through restraining Treg cell differentiation and activation in tumor-bearing mice. ...
Here, we show that the clinically approved compound ursodeoxycholic acid (UDCA), by degrading TGF-beta, enhances antitumor imm …
Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.
Paumgartner G, Beuers U. Paumgartner G, et al. Clin Liver Dis. 2004 Feb;8(1):67-81, vi. doi: 10.1016/S1089-3261(03)00135-1. Clin Liver Dis. 2004. PMID: 15062194 Review.
Ursodeoxycholic acid (UDCA) is widely used for the treatment of cholestatic liver diseases. ...
Ursodeoxycholic acid (UDCA) is widely used for the treatment of cholestatic liver diseases. ...
Gut microbiota-derived ursodeoxycholic acid from neonatal dairy calves improves intestinal homeostasis and colitis to attenuate extended-spectrum beta-lactamase-producing enteroaggregative Escherichia coli infection.
He Z, Ma Y, Yang S, Zhang S, Liu S, Xiao J, Wang Y, Wang W, Yang H, Li S, Cao Z. He Z, et al. Microbiome. 2022 May 28;10(1):79. doi: 10.1186/s40168-022-01269-0. Microbiome. 2022. PMID: 35643532 Free PMC article.
Thus, supplementary foods as alternatives to antibiotics are needed to prevent colibacillus diarrhea in neonatal dairy calves. Ursodeoxycholic acid (UDCA), a therapeutic bile acid, helps alleviate colitis. However, how UDCA helps alleviate ESBL-EAEC-induced c …
Thus, supplementary foods as alternatives to antibiotics are needed to prevent colibacillus diarrhea in neonatal dairy calves. Ursodeoxyc …
Seladelpar: First Approval.
Hoy SM. Hoy SM. Drugs. 2024 Nov;84(11):1487-1495. doi: 10.1007/s40265-024-02114-4. Epub 2024 Nov 22. Drugs. 2024. PMID: 39572508 Review.
On 14 August 2024, based on a reduction in alkaline phosphatase (ALP), it received accelerated approval in the USA for the treatment of PBC in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA, or as monotherapy in patien …
On 14 August 2024, based on a reduction in alkaline phosphatase (ALP), it received accelerated approval in the USA for the treatment of PBC …
Ursodiol in patients with parenteral nutrition-associated cholestasis.
San Luis VA, Btaiche IF. San Luis VA, et al. Ann Pharmacother. 2007 Nov;41(11):1867-72. doi: 10.1345/aph.1K229. Epub 2007 Oct 2. Ann Pharmacother. 2007. PMID: 17911205 Free article. Review.
OBJECTIVE: To review the role of ursodeoxycholic acid (ursodiol) in treating parenteral nutrition-associated cholestasis (PNAC). DATA SOURCES: A MEDLINE (1950-May 2007) search was performed using the key terms parenteral nutrition, cholestasis, ursodeoxych …
OBJECTIVE: To review the role of ursodeoxycholic acid (ursodiol) in treating parenteral nutrition-associated cholestasi …
Ursodiol for hepatobiliary disorders.
Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Rubin RA, et al. Ann Intern Med. 1994 Aug 1;121(3):207-18. doi: 10.7326/0003-4819-121-3-199408010-00009. Ann Intern Med. 1994. PMID: 8017748 Review.
PURPOSE: To explain the rationale supporting the use of ursodiol (ursodeoxycholic acid) for the treatment of patients with cholesterol gallstones and chronic liver diseases and to describe the results obtained in clinical trials. ...DATA SYNTHESIS: Ursodio …
PURPOSE: To explain the rationale supporting the use of ursodiol (ursodeoxycholic acid) for the treatment of patients w …
Ursodiol to prevent hepatic venoocclusive disease.
Comcowich SA, Spitzer TR, Tsunoda SM. Comcowich SA, et al. Ann Pharmacother. 1997 Oct;31(10):1249-52. Ann Pharmacother. 1997. PMID: 9337452 Review.
The studies, although small and not without weakness, suggested that ursodiol effectively reduces the incidence of VOD in allogeneic BMT patients. They do not, however, suggest that ursodiol is effective as treatment for existing VOD, as this was not studied. ...In …
The studies, although small and not without weakness, suggested that ursodiol effectively reduces the incidence of VOD in allogeneic …
[Bile acids in arrhythmia].
Yan JJ, Fan HQ, Yang L. Yan JJ, et al. Zhonghua Gan Zang Bing Za Zhi. 2020 Apr 20;28(4):361-364. doi: 10.3760/cma.j.cn501113-20190308-00074. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32403891 Review. Chinese.
Ursodeoxycholic acid (UDCA) is currently found to have protective effect on the heart and has an antiarrhythmic effect. This article mainly reviews the function and mechanism of bile acid in arrhythmia....
Ursodeoxycholic acid (UDCA) is currently found to have protective effect on the heart and has an antiarrhythmic effect. This a …
ALSUntangled no. 25: ursodiol.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):475-8. doi: 10.3109/21678421.2014.931010. Epub 2014 Jun 27. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24972316 Review. No abstract available.
7,305 results